Evotec SE
EVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412558
No open-market purchases or sales by Evotec SE insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $9.07M in total; no superinvestor holds it.
Other share classesEVOTF
Q3 2024 vs. Q2 2024
How the institutions holding Evotec SE changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 28 | 1 | 24 | −3 |
| Shares | 7.29M | 82.6K | 7.98M | +772.0K (+10.7%) |
| Value | $35.0M | $396.5K | $29.6M | −$5.00M (−14.4%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Evotec SE at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mediolanum International Funds Ltd | 140,383 | $984.7K | 0.01% |
| BlackRock, Inc. | 51,163 | $186.7K | 0.00% |
| Clear Harbor Asset Management, LLC | 28,600 | $104.4K | 0.01% |
| Principal Securities, Inc. | 42 | $153 | 0.00% |
Sold out (7)
Institutions that held Evotec SE at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| JustInvest LLC | 19,233 | $87.1K |
| ADAR1 Capital Management, LLC | 9,400 | $45.1K |
| HHM Wealth Advisors, LLC | 450 | $2.16K |
| EverSource Wealth Advisors, LLC | 111 | $528 |
| Tower Research Capital LLC (TRC) | 109 | $523 |
| Qube Research & Technologies Ltd | 59 | $283 |
| Royal Bank of Canada | 149 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held Evotec SE at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 82,598 | $396.5K |